Cubresa today announced that it has received investment from the Manitoba Knights. The $500,000 Series A investment will be used to support the development of a compact SPECT imager for the preclinical imaging market.
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
About Us
Leadership
Technology
Careers
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4